-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
eFFECTOR Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q1 2024.
- eFFECTOR Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 4.08M shares, a 143% increase year-over-year.
- eFFECTOR Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.19M shares, a 32.8% increase from 2022.
- eFFECTOR Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.65M shares, a 95.4% decline from 2021.
- eFFECTOR Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 36M shares, a 1256% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)